Maddukkur, India

Sankar Ramakrishnan

This inventor holds 1 USPTO granted patent. Top assignee: Diakron Pharmaceuticals, Inc.. Active years: 2018.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Sankar Ramakrishnan. Retrieved from https://idiyas.com/inventor/sankar-ramakrishnan

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2018

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Sankar Ramakrishnan

Introduction

Sankar Ramakrishnan is a notable inventor based in Maddukkur, India. He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative drug formulations. His work focuses on improving the efficacy and delivery of medications.

Latest Patents

Sankar holds a patent for an extended release formulation of a direct thrombin inhibitor. This formulation, known as DPOC-4088, is designed to provide better control of blood plasma levels. The extended release formulations maintain substantially constant plasma levels of the active ingredient for at least about 16 hours, allowing for once-daily dosing. This innovation represents a significant advancement in the management of anticoagulation therapy.

Career Highlights

Sankar Ramakrishnan is currently associated with Diakron Pharmaceuticals, Inc., where he continues to work on developing cutting-edge pharmaceutical solutions. His expertise in drug formulation has positioned him as a valuable asset in the industry.

Collaborations

Sankar collaborates with talented professionals in his field, including Elumalal Venkatesan and Jayanthi Suryakumar. These collaborations enhance the research and development efforts at Diakron Pharmaceuticals.

Conclusion

Sankar Ramakrishnan's contributions to pharmaceutical innovations, particularly in drug formulation, highlight his commitment to improving patient care. His work continues to influence the field and pave the way for future advancements in medication delivery.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…